Six months of recombinant human GH therapy in patients with ischemic cardiac failure does not influence left ventricular function and mass

Journal of Clinical Endocrinology and Metabolism

Volumn 86, Issue 10, 2001, Pages 4638-4643

  Smit, Jan W A ^a   Janssen, Yvonne J H ^a   Lamb, Hildo J ^a   Van Der Wall, Ernst E ^a   Stokkel, Marcel P M ^a   Viergever, Eric ^b   Biermasz, Nienke R ^a   Bax, Jeroen J ^a   Vliegen, Hubert W ^a   De Roos, Albert ^a   Romijn, Johannes A ^a   Roelfsema, Ferdinand ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b GROENE HART HOSPITAL   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

HUMAN GROWTH HORMONE;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; FEMALE; GROWTH HORMONE DEFICIENCY; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE FUNCTION; HEART VENTRICLE ENDDIASTOLIC PRESSURE; HORMONE ACTION; HUMAN; ISCHEMIC HEART DISEASE; MALE; PRIORITY JOURNAL; TREATMENT OUTCOME;

EID: 0344341757     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jcem.86.10.7832     Document Type: Article

References (29)

1. Cardiovascular effects of short-term growth hormone hypersecretion
2. Impaired cardiac performance is a distinct feature of uncomplicated acromegaly
3. Impaired cardiac performance in GH-deficient adults and its improvement after GH replacement
4. Long-term growth hormone treatment in growth hormone deficient adults
5. Cardiac performance and mass in adults with hypopituitarism: Effects of one year of growth hormone treatment
6. Effects of chronic growth hormone hypersecretion on intrinsic contractility, energetics, isomyosin pattern, and myosin adenosine triphosphatase activity of rat left ventricle
7. Insulin-like growth factor I stimulates myofibril development and decreases smooth muscle α-actin of adult cardiomyocytes
8. Insulin-like growth factor-1 enhances ventricular hypertrophy and function during the onset of experimental cardiac failure
9. Growth hormone attenuates early left ventricular remodeling and improves cardiac function in rats with large myocardial infarction
10. Growth hormone improves cardiac function in rats with experimental myocardial infarction
11. A preliminary study of growth hormone in the treatment of dilated cardiomyopathy
12. Randomised, double-blind, placebo-controlled trial of human recombinant growth hormone in patients with chronic heart failure due to dilated cardiomyopathy
13. A placebo-controlled study of growth hormone in patients with congestive heart failure
14. The somatotrophic system in patients with dilated cardiomyopathy: Relation of insulin-like growth factor-1 and its alterations during growth hormone therapy to cardiac function
15. Recombinant growth hormone therapy in patients with ischemic cardiomyopathy: Effects on hemodynamics, left ventricular function, and cardiopulmonary exercise capacity
16. Evaluation of growth hormone administration in patients with chronic heart failure secondary to coronary artery disease
17. The severity of chronic heart failure due to coronary artery disease predicts the endocrine effects of short-term growth hormone administration
18. Automatic quantification of ejection fraction from gated myocardial perfusion SPECT
19. Myocardial SPET imaging with 99Tcm-tetrofosmin in clinical practice: Comparison of a 1 day and a 2 day imaging protocol
20. No gender bias in referral for coronary angiography after myocardial perfusion scintigraphy with technetium-99m tetrofosmin
21. Echo planar MRI of the heart on a standard system: Validation of measurements of left ventricular function and mass
22. Diastolic dysfunction in hypertensive heart disease is associated with altered myocardial metabolism
23. Comparison between manual and semiautomated analysis of left ventricular volume parameters from short-axis MR images
24. Left ventricular measurements with cine and spin-echo MR imaging: A study of reproducibility with variance component analysis
25. Growth hormone-releasing peptide-2 infusion synchronizes growth hormone, thyrotrophin and prolactin release in prolonged critical illness
26. Deficient insulin-like growth factor I in chronic heart failure predicts altered body composition, anabolic deficiency, cytokine and neurohormonal activation
27. Hormonal changes and catabolic/anabolic imbalance in chronic heart failure and their importance for cardiac cachexia
28. Beneficial effects of growth hormone and insulin-like growth factor-1 in experimental heart failure in rats treated with chronic ACE inhibition
29. Progressive cardiac dysfunction and fibrosis in the cardiomyopathie hamster and effects of growth hormone and angiotensin-converting enzyme inhibition